Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/ajt.16185 http://scihub22266oqcxt.onion/10.1111/ajt.16185 32649791!7405285!32649791     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Am+J+Transplant 2020 ; 20 (11): 3140-3148 Nephropedia Template TP {{tp|p=32649791|t=2020. COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium |pdf=|usr=}}{{32649791}} gab.com Text COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium JO: Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32649791 #FOAvip Kidney transplant recipients may be at a high risk of developing critical coronavirus disease 2019 (COVID-19) illness due to chronic immunosuppression and comorbidities. We identified hospitalized adult kidney transplant recipients at 12 transplant centers in the United States, Italy, and Spain who tested positive for COVID-19. Clinical presentation, laboratory values, immunosuppression, and treatment strategies were reviewed, and predictors of poor clinical outcomes were determined through multivariable analyses. Among 9845 kidney transplant recipients across centers, 144 were hospitalized due to COVID-19 during the 9-week study period. Of the 144 patients, 66% were male with a mean age of 60 (+/-12) years, and 40% were Hispanic and 25% were African American. Prevalent comorbidities included hypertension (95%), diabetes (52%), obesity (49%), and heart (28%) and lung (19%) disease. Therapeutic management included antimetabolite withdrawal (68%), calcineurin inhibitor withdrawal (23%), hydroxychloroquine (71%), antibiotics (74%), tocilizumab (13%), and antivirals (14%). During a median follow-up period of 52 days (IQR: 16-66 days), acute kidney injury occurred in 52% cases, with respiratory failure requiring intubation in 29%, and the mortality rate was 32%. The 46 patients who died were older, had lower lymphocyte counts and estimated glomerular filtration rate levels, and had higher serum lactate dehydrogenase, procalcitonin, and interleukin-6 levels. In sum, hospitalized kidney transplant recipients with COVID-19 have higher rates of acute kidney injury and mortality. Twit Text FOAVip COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium ????Am J Transplant http://www.kidney.de/pget.php?&tw=1&pmid=32649791 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32649791 #FOAvip English Wikipedia <ref>{{Cite pmid|32649791}}</ref> COVID-19 and kidney transplantation: Results from the TANGO International Transplant Consortium #MMPMID32649791 Cravedi P; Mothi SS; Azzi Y; Haverly M; Farouk SS; Perez-Saez MJ; Redondo-Pachon MD; Murphy B; Florman S; Cyrino LG; Grafals M; Venkataraman S; Cheng XS; Wang AX; Zaza G; Ranghino A; Furian L; Manrique J; Maggiore U; Gandolfini I; Agrawal N; Patel H; Akalin E; Riella LV Am J Transplant 2020[Nov]; 20 (11): 3140-3148 PMID32649791show ga Kidney transplant recipients may be at a high risk of developing critical coronavirus disease 2019 (COVID-19) illness due to chronic immunosuppression and comorbidities. We identified hospitalized adult kidney transplant recipients at 12 transplant centers in the United States, Italy, and Spain who tested positive for COVID-19. Clinical presentation, laboratory values, immunosuppression, and treatment strategies were reviewed, and predictors of poor clinical outcomes were determined through multivariable analyses. Among 9845 kidney transplant recipients across centers, 144 were hospitalized due to COVID-19 during the 9-week study period. Of the 144 patients, 66% were male with a mean age of 60 (+/-12) years, and 40% were Hispanic and 25% were African American. Prevalent comorbidities included hypertension (95%), diabetes (52%), obesity (49%), and heart (28%) and lung (19%) disease. Therapeutic management included antimetabolite withdrawal (68%), calcineurin inhibitor withdrawal (23%), hydroxychloroquine (71%), antibiotics (74%), tocilizumab (13%), and antivirals (14%). During a median follow-up period of 52 days (IQR: 16-66 days), acute kidney injury occurred in 52% cases, with respiratory failure requiring intubation in 29%, and the mortality rate was 32%. The 46 patients who died were older, had lower lymphocyte counts and estimated glomerular filtration rate levels, and had higher serum lactate dehydrogenase, procalcitonin, and interleukin-6 levels. In sum, hospitalized kidney transplant recipients with COVID-19 have higher rates of acute kidney injury and mortality. |*Pandemics[MESH] |*SARS-CoV-2[MESH] |*Transplant Recipients[MESH] |Aged[MESH] |COVID-19/*epidemiology[MESH] |Comorbidity[MESH] |Europe/epidemiology[MESH] |Female[MESH] |Follow-Up Studies[MESH] |Graft Rejection/epidemiology/*prevention & control[MESH] |Humans[MESH] |Immunocompromised Host[MESH] |Immunosuppression Therapy/*methods[MESH] |Immunosuppressive Agents/therapeutic use[MESH] |Kidney Transplantation/*statistics & numerical data[MESH] |Male[MESH] |Middle Aged[MESH] |North America/epidemiology[MESH]COVID-19 and kidney transplantation: Results from the TANGO Internatio(epmc).pdf DeepDyve Pubget Overpricing